Cape Town, South Africa
08048034875
+919359902383
ANTI CANCER MEDICINE

Jemperli 500mg Injection Supplier & Exporter from India | Dostarlimab Immunotherapy Cancer Medicine USA, UK, UAE, Australia, Singapore – Ernest Oncology

In stockcod not available
Phone Number

08048034875

Please keep 0 before dialling the number.

Mon-Thu: 10 AM - 2 PM • Fri: 3 PM - 7AM

Other Website Visit our other website
Address Cape Town , City of Cape Town Metropolitan Municipality , Western Cape

Cape Town, South Africa, India, 1

Description

Jemperli 500mg Injection (Dostarlimab) – Global Supplier & Exporter | Ernest Oncology Jemperli 500mg Injection Jemperli 500mg Injection contains Dostarlimab, an advanced immunotherapy medicine used in the treatment of certain types of endometrial cancer and other solid tumors. It belongs to the class of PD-1 immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells. Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a trusted global exporter and bulk supplier of oncology medicines, supplying Jemperli 500mg injections to hospitals, oncology centers, pharmaceutical distributors, and international wholesalers worldwide. What is Jemperli 500mg Injection? Jemperli is a monoclonal antibody immunotherapy designed to treat cancers with mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) characteristics. The medicine works by activating the immune system to detect and destroy cancer cells. This targeted immunotherapy helps improve treatment outcomes for patients with advanced cancers. Mechanism of Action Dostarlimab works by blocking the Programmed Death-1 (PD-1) receptor found on immune cells. Its mechanism includes: • Blocking the PD-1 immune checkpoint pathway • Enhancing immune system response against cancer cells • Restoring the body’s ability to detect and destroy tumor cells • Slowing cancer growth and progression Indications Jemperli 500mg Injection is used for the treatment of: • Endometrial Cancer with dMMR or MSI-H • Advanced or Recurrent Endometrial Cancer • Certain solid tumors with mismatch repair deficiency It is generally used when cancer has progressed after other treatments. Dosage & Administration Typical dosage guidelines: • 500 mg administered intravenously every 3 weeks • Later adjusted to 1000 mg every 6 weeks depending on treatment protocol • Given as an IV infusion in hospital or clinical settings Treatment should be administered under the supervision of an oncologist. Key Benefits of Jemperli 500mg Injection ✔ Advanced immunotherapy for cancer treatment ✔ Activates the immune system to fight cancer ✔ Effective for dMMR / MSI-H tumors ✔ Helps control tumor progression ✔ Targeted monoclonal antibody therapy Possible Side Effects Some patients may experience: • Fatigue • Nausea • Diarrhea • Skin rash • Fever • Immune-related reactions Patients should be monitored regularly during treatment. Product Specifications Product Name: Jemperli Generic Name: Dostarlimab Strength: 500 mg Dosage Form: Injection Therapeutic Class: Anti-Cancer / Immunotherapy / PD-1 Inhibitor Packaging: Vial Storage: Store in refrigerator (2°C – 8°C), do not freeze Ernest Oncology supplies Jemperli 500mg injections worldwide, including: USA • United Kingdom • UAE • Saudi Arabia • Australia • Singapore • South Africa • Thailand • Jamaica • Europe • Africa • Middle East • Latin America We supply to: • Oncology hospitals • Cancer treatment centers • Pharmaceutical distributors • Government healthcare tenders • International wholesalers Why Buy From Ernest Oncology? ✔ Trusted Oncology Medicine Exporter from India ✔ Competitive bulk and wholesale pricing ✔ 100% genuine pharmaceutical products ✔ GMP compliant supply ✔ Worldwide delivery via DHL / FedEx / Aramex ✔ Reliable B2B pharmaceutical partner Export Documentation Provided • Certificate of Analysis (COA) • MSDS (Material Safety Data Sheet) • Batch Release Certificate • Commercial Invoice • Packing List • Airway Bill • GMP Certificates 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymedicinesupplier.com www.ernestempex.com www.ernestvision.com 📧 Email exports@ernestpharmaceuticals.com 📦 Business Type Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 https://wa.me/919359902383

Keywords

Other Products

view all

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

The Comprehensive Guide to Temalieva 250 mg Capsules In precision neuro-oncology and general cancer care, Temalieva 250 mg capsules (containing the active ingredient Temozolomide) stand as a critical therapeutic agent for treating aggressive brain tumors. As a premier pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this life-saving medication is accessible to hospitals, pharmacies, and healthcare systems in London, the UK, the USA, Australia, and South Africa with full regulatory compliance. Product SpecificationsFeatureDetailBrand NameTemalieva 250 (Temozolomide Capsules IP)Strength250 mgDosage FormOral Hard Gelatin CapsulePrimary IndicationGlioblastoma multiforme & anaplastic astrocytomaStorageStore below 25°C in a cool, dry place. Protect from moisture and light. Mechanism of Action: How It Works DNA Alkylation: Once ingested, Temozolomide readily crosses the blood-brain barrier. At physiological pH, it is converted into the active compound MTIC. Interfering with Replication: MTIC methylates DNA at specific locations, which causes DNA strand breaks and cross-linking. This process inhibits the multiplication and growth of rapidly dividing cancer cells, ultimately leading to programmed cell death (apoptosis). Therapeutic Indications & Administration Glioblastoma Multiforme (GBM): Used for newly diagnosed GBM patients in combination with focal radiation therapy, followed by maintenance therapy. Refractory Anaplastic Astrocytoma: Treatment for patients experiencing tumor recurrence or progression after standard therapy. Administration Guidelines Dosing Schedule: Dosing is calculated based on the patient's body surface area (BSA). Ingestion: Swallow the capsules whole with a full glass of water. Do not open, crush, or chew the capsule contents to prevent exposure to the active drug. Minimizing Side Effects: To reduce the incidence of nausea and vomiting, patients are often advised to take the medication on an empty stomach or at bedtime. Clinical Side Effects & Safety Profile Common Side Effects: Nausea, vomiting, headache, fatigue, constipation, and loss of appetite. Prophylactic antiemetics are frequently prescribed. Myelosuppression: The most serious clinical risk is a decrease in bone marrow function, which leads to reduced white blood cell and platelet counts. This increases susceptibility to infections and bruising or bleeding. Liver Function: Patients should undergo regular liver function tests (LFTs) due to the potential for hepatotoxicity. Contraindications: It is contraindicated during pregnancy and breastfeeding due to the risk of fetal harm. Male patients must use effective contraception during treatment and for at least 3 months afterward. Why Source from Ernest Oncology? United Kingdom (London): Providing high-quality, cost-effective generic alternatives for private and public healthcare systems. USA: Delivering bulk quantities that comply with international documentation and safety standards. Australia: Facilitating secure access through compliant supply channels such as the “Special Access Scheme“ (SAS). South Africa: Bridging critical gaps in the oncology market with affordable, high-tier pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

Comprehensive Product Authority Guide: Temalieva 20mg (Temozolomide) Temalieva 20mg, formulated with the active pharmaceutical ingredient Temozolomide, is a potent oral alkylating antineoplastic agent. It is widely recognized and utilized in neuro-oncology for the treatment of aggressive forms of brain tumors. 1. Advanced Mechanism of Action DNA Methylation: MTIC works by methylating DNA at the O6 and N7 positions of guanine. Cell Cycle Arrest: This methylation damages the genetic material of cancer cells, leading to DNA double-strand breaks and inducing apoptosis (programmed cell death) in rapidly dividing tumor cells. Blood-Brain Barrier Penetration: Because it is highly lipophilic, it crosses the blood-brain barrier easily, making it uniquely effective against primary and secondary brain malignancies. 2. Therapeutic Indications Glioblastoma Multiforme (GBM): Administered in combination with focal radiotherapy as an initial treatment, followed by maintenance therapy to prevent recurrence. Anaplastic Astrocytoma: Prescribed for patients with refractory or progressive malignant glioma, including anaplastic astrocytoma. Other Malignancies: Clinical evaluation has shown efficacy in certain systemic cancers and targeted neuro-oncology protocols. 3. Dosage and Administration Strength: Available as 20mg oral capsules. Administration Protocol: To minimize nausea and ensure consistent bioavailability, the medication should be taken consistently (either always on an empty stomach or always with a light meal) at the same time each day. Handling Instructions: Capsules must be swallowed whole with a full glass of water. They should not be opened, chewed, crushed, or split, as the contents are highly cytotoxic. 4. Safety Profile and Side Effect Management Common Side Effects: Nausea, vomiting, fatigue, headache, and constipation. Hematological Effects: Myelosuppression (reduced red/white blood cell and platelet counts), which increases the risk of serious infections. Monitoring: Frequent complete blood counts (CBC) and liver function tests are recommended throughout the treatment cycle. Why Source from Ernest Oncology? Ernest Oncology—a specialized division of Ernest Pharmaceutical Pvt. Ltd.—is a trusted global exporter, bulk supplier, and distributor. We facilitate the secure, temperature-controlled delivery of life-saving specialty pharmaceuticals worldwide, bridging the gap between state-of-the-art manufacturing in India and the requirements of global healthcare networks. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383

68179d65be22ee500d53ff54 Card 2

product image
ANTI CANCER MEDICINE

The Comprehensive Guide to Leuprolide 11.25mg Injection In modern oncology and endocrinology, Leuprolide 11.25mg Injection serves as a vital medication for managing hormone-dependent conditions and advanced cancers. As a leading pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) ensures that this life-saving medication is accessible with full regulatory compliance to healthcare providers and patients in London, New York, Sydney, Johannesburg, and across the globe. Product Specifications Brand Name: Ernest-Oncology (Leuprolide Acetate) Strength: 11.25 mg Dosage Form: Depot Suspension for Injection (Intramuscular/Subcutaneous) Primary Indication: Management of prostate cancer, endometriosis, uterine fibroids, and central precocious puberty Storage: Store at room temperature (20°C to 25°C), protect from light and moisture Mechanism of Action: How It Works Initial Stimulation: During the first few weeks of administration, it stimulates the pituitary gland to release an increased amount of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Down-Regulation and Suppression: Continued use desensitizes the pituitary gland. As a result, the production of LH and FSH drops, significantly decreasing the production of testosterone in males and estrogen in females. Halting Cancer and Abnormal Growth: By eliminating the hormones that stimulate cancer cells or abnormal tissue growth (such as in prostate cancer or endometriosis), the progression of the disease is successfully halted. Therapeutic Indications & Administration Prostate Cancer: Palliative treatment for advanced prostate cancer to lower testosterone levels. Endometriosis & Uterine Fibroids: Relieves painful symptoms by lowering estrogen and shrinking abnormal tissues. Central Precocious Puberty: Safely delays puberty in children until an appropriate age. Administration: * Route: Given as an intramuscular or subcutaneous injection. Professional Use: Administered strictly by a healthcare professional or trained nurse in a clinical setting. Schedule: Typically given once every 3 months, based on the patient's specific treatment protocol. Clinical Side Effects & Safety Hormonal Effects: Hot flashes, increased sweating, fatigue, and decreased sex drive are very common. Bone Density Loss: Long-term use can lead to weakened bones (osteoporosis). Calcium and Vitamin D supplementation may be advised. Psychiatric and Neurological Effects: Mood swings, depression, or emotional changes (such as irritability or crying) may occur. Serious Warnings: Risk of increased blood sugar levels in diabetic patients and rare reports of severe skin reactions or QT prolongation. Contraindication: It is strictly contraindicated during pregnancy due to the high risk of fetal harm or miscarriage. Why Source from Ernest Oncology? United Kingdom (London): Supplying cost-effective oncology and endocrinology solutions to meet the needs of both private and public healthcare providers. USA: Delivering bulk supply solutions that meet stringent quality and documentation benchmarks. Australia: Facilitating access to essential medications through established “Special Access Scheme“ (SAS) channels. South Africa: Bridging critical gaps in the regional market with reliable, high-quality pharmaceutical exports from India. 📞 Contact Ernest Oncology — Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 📦 Business Type: Exporter | Bulk Supplier | Distributor 🌐 Websites: www.oncologymedicinesupplier.com www.ernestpharmaceuticals.com www.ernestvision.com www.ernestimpex.com 📧 Email: exports@ernestpharmaceuticals.com 📲 WhatsApp: +91 93599 02383 🔗 Direct Link: https://wa.me/919359902383